4//SEC Filing
bluebird bio, Inc. 4
Accession 0001209191-17-011821
CIK 0001293971operating
Filed
Feb 16, 7:00 PM ET
Accepted
Feb 17, 8:41 AM ET
Size
9.0 KB
Accession
0001209191-17-011821
Insider Transaction Report
Form 4
Mandell James
Director
Transactions
- Sale
Common Stock
2017-02-15$80.22/sh−1,050$84,235→ 1,000 total - Exercise/Conversion
Stock Option (right to buy)
2017-02-15+1,050→ 4,500 totalExercise: $25.16Exp: 2024-06-11→ Common Stock (1,050 underlying) - Exercise/Conversion
Common Stock
2017-02-15$25.16/sh+1,050$26,418→ 2,050 total
Footnotes (3)
- [F1]This sales reported in the Form 4 were effectd pursuant to a 10b5-1 trading plan adopted by the reporting person on December 13, 2016.
- [F2]The range in prices for the transaction reported on this line was $80.00 to $80.50. The average weighted price was $80.2236. The reporting person will provide, upon request by the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
- [F3]This option vests 100% on the earlier of June 11, 2015 or the date of the next annual meeting of stockholders.
Documents
Issuer
bluebird bio, Inc.
CIK 0001293971
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001293971
Filing Metadata
- Form type
- 4
- Filed
- Feb 16, 7:00 PM ET
- Accepted
- Feb 17, 8:41 AM ET
- Size
- 9.0 KB